# Questions for Oncologists
\
However, if you have not yet discussed P53 germline testing with your oncologist yet and need support with that task of requesting a test, read this expanding section below:
Here is what to say — or hand to the oncologist in writing:
> I am aware that there are guidelines state that germline TP53 testing must be performed before treatment initiation, because radiotherapy and genotoxic chemotherapy carry a documented risk of inducing secondary malignancies in germline TP53 carriers. I am not asking you to assume I have this variant — I am asking you to order the test so that my treatment is designed with full information. The standard of care in 2026 is precision medicine — not trial and error on patients who have a right to know their genetic profile before decisions are made. I do not consent to a 'wait and see' approach when a simple blood test can provide information that changes the treatment map entirely.\
> (Guideline sources: ERN GENTURIS, GeneReviews/NIH, and eviQ Australia)
The aim is not to overwhelm you or the oncologist at the clinic visit. It is to make sure the right distinctions are actually discussed.
### First: clarify what kind of TP53 result this is
These are the first two questions because they prevent confusion early:
1. **Is this result from a tumour/somatic test or from a hereditary/germline panel?**
2. **Is there a specific variant code or description listed next to TP53?**
Without those two answers, people often talk past each other.
### Questions after a *germline* TP53 result
If the result shows that a germline TP53 mutation is confirmed, useful questions include:
1. **Has my germline TP53 finding been clearly communicated to the oncology team and integrated into treatment planning?**
2. **Does any part of my current or planned treatment rely on radiotherapy or genotoxic chemotherapy, and has my TP53 status been considered in that decision?**
3. **If radiotherapy is being considered, what specific risks and alternatives have been discussed in light of this result?**
4. **Should I be referred to a familial cancer or heritable TP53 specialist service?**
5. **Do I need a structured surveillance plan because of this finding?**
These questions matter because germline TP53 is not just a genetics-lab issue. It can change how treatment risk is framed.
***
### Questions if/when the tumour TP53 (somatic) result is the key issue
If the main question is tumour behaviour rather than inherited risk, ask:
1. **Do we know whether my tumour TP53 is wild-type, mutant, or effectively null?**
2. **What exact TP53 variant was found on the tumour test?**
3. **Does this mutation class help explain resistance, aggressiveness, or trial eligibility?**
4. **Was this result found on tissue testing, liquid biopsy, or inferred from pathology staining?**
5. **Could any blood-based TP53 finding reflect clonal haematopoiesis rather than tumour DNA?**
These questions help stop a vague "TP53 mutation" label from substituting for real interpretation.
### Questions when both the inherited and tumour results may matter
Sometimes the most useful question is the paired one:
**Could I have paired somatic-germline TP53 testing, or a proper review of both together, rather than discussing only one layer in isolation?**
That matters when the issue is not just whether a person carries a variant, but what the tumour has done with the remaining TP53 biology.
### Questions tied to practical treatment choices
Useful wording includes:
* **Does this TP53 result affect how you think about likely treatment response or resistance?**
* **Does it change how you interpret radiotherapy risk, chemotherapy choice, or monitoring?**
* **Are there treatment or trial decisions where this mutation class becomes especially relevant?**
### If the team seems dismissive
The most grounded response is not confrontation. It is specificity.
Try:
* **I am not asking you to speculate. I am asking what this exact TP53 result means for treatment planning.**
* **I would like to understand whether this is a germline issue, a tumour issue, or both.**
* **If this requires genetics input or specialist review, can we arrange that rather than leaving the question unresolved?**
### Australian note
For Australian readers, it can be reasonable to ask directly whether:
* eviQ guidance has been considered
* referral to a familial-cancer service is appropriate
* specialist review is needed when a germline issue may affect treatment planning
### Get a copy of the report
The most useful practical step is often simple:
Leave the appointment with an actual report, or have them email it to you before you leave the clinic.
That allows you to go away knowing you will be able to communicate
* the correct test type
* the exact variant
* the specimen type
* the wording used by the lab
### Bottom line
The most important clinic questions are the ones that force clarity on:
* test type
* exact variant
* mutation class
* treatment-planning consequences
That is how a TP53 result becomes usable rather than just alarming or baffling.
### Bookmark this page
Bookmark it for easy access when you're at your oncology appointment to receive results.
### Where to go next
* Use [Why Test Type Matters](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/why-test-type-matters.md) if the clinician conversation keeps mixing germline and tumour questions.
* Use [Germline TP53](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/germline-tp53.md) for inherited-risk and treatment-planning questions.
* Use [Somatic TP53](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/somatic-tp53.md) and [TP53 Mutation Types Reference](/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/somatic-tp53/tp53-mutation-types-reference.md) if the issue is tumour interpretation.
{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}
{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}
---
# Agent Instructions: Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter:
```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/questions-for-oncologists.md?ask=
```
The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.